BioGaia AB (publ)
SSE:BIOG-B.ST
124.4 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | BioGaia AB (publ) |
Symbool | BIOG-B.ST |
Munteenheid | SEK |
Prijs | 124.4 |
Beurswaarde | 12,101,507,600 |
Dividendpercentage | 3.72% |
52-weken bereik | 87.95 - 128.7 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Isabelle Valerie Ghislaine Ducellier |
Website | https://www.biogaia.com |
An error occurred while fetching data.
Over BioGaia AB (publ)
BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide. It operates through three segments: Pediatrics, Adult Health, and Other. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)